TD Cowen Lowers Beauty Health (NASDAQ:SKIN) Price Target to $1.50

Beauty Health (NASDAQ:SKIN) had its price target reduced by stock analysts at TD Cowen from $1.65 to $1.50 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen’s price target suggests a potential upside of 14.50% from the company’s current price.

Several other research analysts also recently commented on SKIN. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $1.50 price target on shares of Beauty Health in a research note on Friday. Zacks Research downgraded shares of Beauty Health from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 21st. Jefferies Financial Group restated a “hold” rating and issued a $1.60 target price on shares of Beauty Health in a research note on Wednesday, January 14th. Finally, Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a research note on Friday. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, Beauty Health currently has an average rating of “Reduce” and an average target price of $2.42.

Beauty Health Trading Up 3.1%

Beauty Health stock traded up $0.04 during midday trading on Monday, reaching $1.31. The stock had a trading volume of 215,195 shares, compared to its average volume of 633,171. Beauty Health has a 52-week low of $0.78 and a 52-week high of $2.69. The company has a quick ratio of 1.40, a current ratio of 1.66 and a debt-to-equity ratio of 3.94. The firm has a market cap of $167.03 million, a price-to-earnings ratio of -6.55 and a beta of 1.20. The company has a fifty day moving average of $1.27 and a 200 day moving average of $1.51.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings data on Thursday, March 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Beauty Health had a negative return on equity of 15.40% and a negative net margin of 3.16%.The company had revenue of $82.37 million during the quarter, compared to analysts’ expectations of $78.07 million. On average, analysts anticipate that Beauty Health will post -0.25 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Beauty Health

Several institutional investors have recently bought and sold shares of the business. AQR Capital Management LLC purchased a new stake in Beauty Health during the first quarter worth $40,000. Goldman Sachs Group Inc. increased its holdings in shares of Beauty Health by 5.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock valued at $892,000 after acquiring an additional 31,880 shares during the period. ProShare Advisors LLC raised its position in shares of Beauty Health by 45.5% in the 2nd quarter. ProShare Advisors LLC now owns 23,447 shares of the company’s stock worth $45,000 after acquiring an additional 7,336 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Beauty Health by 27.5% in the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after acquiring an additional 496,963 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey lifted its stake in shares of Beauty Health by 87.5% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 31,408 shares of the company’s stock worth $60,000 after purchasing an additional 14,653 shares during the last quarter. 93.26% of the stock is owned by hedge funds and other institutional investors.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.